Recombinant SARS-CoV-2 (COVID-

Recombinant SARS-CoV-2 (COVID-19) S-mIgG1 Neutralizing 抗体 [8A5]，Recombinant SARS-CoV-2 (COVID-19) S-mIgG1 Neutralizing Antibody [8A5]，Recombinant SARS-CoV-2 (COVID-19) S-mIgG1 Neutralizing 抗体 [8A5],Recombinant SARS-CoV-2 (COVID-19) S-mIgG1 Neutralizing Antibody [8A5]

产品名称：Recombinant SARS-CoV-2 (COVID-19) S-mIgG1 Neutralizing 抗体 [8A5]-Recombinant SARS-CoV-2 (COVID-19) S-mIgG1 Neutralizing Antibody [8A5]

产品货号：PSI-93-305-0.05mg

产品规格：0.05mg

背景资料：The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

保存建议：Recombinant SARS-CoV-2 (COVID-19) S-mIgG1 Neutralizing 抗体 [8A5]-Recombinant SARS-CoV-2 (COVID-19) S-mIgG1 Neutralizing Antibody [8A5]24 months from manufacturing at <-20 ℃; 1 month, 2 to 8 ℃ under sterile conditions

应用类型：E, Neut

点击：Recombinant SARS-CoV-2 (COVID-19) S-mIgG1 Neutralizing 抗体 [8A5]-Recombinant SARS-CoV-2 (COVID-19) S-mIgG1 Neutralizing Antibody [8A5]查看更详细产品说明，更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多ProSci公司特色试剂盒、特色抗体以及特色试剂等产品评论，请点击查看艾美捷特色产品中心。